| Product Code: ETC12732969 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Africa Neoantigen Market Overview |
3.1 South Africa Country Macro Economic Indicators |
3.2 South Africa Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 South Africa Neoantigen Market - Industry Life Cycle |
3.4 South Africa Neoantigen Market - Porter's Five Forces |
3.5 South Africa Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Africa Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 South Africa Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 South Africa Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Africa Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing investment in research and development of personalized medicine in South Africa |
4.2.2 Increasing prevalence of cancer cases in the region |
4.2.3 Favorable government initiatives and policies supporting the development of neoantigen therapies |
4.3 Market Restraints |
4.3.1 High costs associated with neoantigen therapy development and treatments |
4.3.2 Limited awareness and understanding of neoantigen therapies among healthcare professionals and patients in South Africa |
5 South Africa Neoantigen Market Trends |
6 South Africa Neoantigen Market, By Types |
6.1 South Africa Neoantigen Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Africa Neoantigen Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 South Africa Neoantigen Market Revenues & Volume, By Personalized Neoantigens, 2021 - 2031F |
6.1.4 South Africa Neoantigen Market Revenues & Volume, By Shared Neoantigens, 2021 - 2031F |
6.2 South Africa Neoantigen Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 South Africa Neoantigen Market Revenues & Volume, By DNA Sequencing, 2021 - 2031F |
6.2.3 South Africa Neoantigen Market Revenues & Volume, By RNA Sequencing, 2021 - 2031F |
6.2.4 South Africa Neoantigen Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.3 South Africa Neoantigen Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 South Africa Neoantigen Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3.3 South Africa Neoantigen Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.3.4 South Africa Neoantigen Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4 South Africa Neoantigen Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 South Africa Neoantigen Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 South Africa Neoantigen Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 South Africa Neoantigen Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
7 South Africa Neoantigen Market Import-Export Trade Statistics |
7.1 South Africa Neoantigen Market Export to Major Countries |
7.2 South Africa Neoantigen Market Imports from Major Countries |
8 South Africa Neoantigen Market Key Performance Indicators |
8.1 Number of research collaborations between pharmaceutical companies and research institutions in South Africa focusing on neoantigens |
8.2 Percentage increase in clinical trials for neoantigen therapies in South Africa |
8.3 Adoption rate of neoantigen therapies by healthcare facilities and oncologists in the region |
8.4 Number of publications and presentations on neoantigen therapy advancements in South Africa |
8.5 Percentage of cancer patients in South Africa eligible for neoantigen therapy treatments |
9 South Africa Neoantigen Market - Opportunity Assessment |
9.1 South Africa Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Africa Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 South Africa Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 South Africa Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Africa Neoantigen Market - Competitive Landscape |
10.1 South Africa Neoantigen Market Revenue Share, By Companies, 2024 |
10.2 South Africa Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here